ZL, M., & NB, M. (2016). Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease. Journal of clinical pharmacology, 56(8), 974. https://doi.org/10.1002/jcph.683
Chicago Style (17th ed.) CitationZL, Mao, and Modi NB. "Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease." Journal of Clinical Pharmacology 56, no. 8 (2016): 974. https://doi.org/10.1002/jcph.683.
MLA (9th ed.) CitationZL, Mao, and Modi NB. "Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease." Journal of Clinical Pharmacology, vol. 56, no. 8, 2016, p. 974, https://doi.org/10.1002/jcph.683.